05 May 2022
05 May 2022
HIGHER SABA USE IS ASSOCIATED WITH ADVERSE CLINICAL OUTCOMES: RESULTS FROM A SURVEY IN MEXICAN PHARMACIES.
05 May 2022
The risk for moderate exacerbations in patients with asthma treated with short-acting beta-agonists only
05 May 2022
How can we tackle SABA over-reliance in asthma management? Rationale and design of the Reliever Reliance Test (RRT) Impact Evaluation project in Argentina
05 May 2022
Healthcare costs associated with short-acting β2-agonist use in asthma: an observational UK study from the SABINA global programme
05 May 2022
From kickstart to full steam ahead for the #RightInhalerImage Campaign
05 May 2022
Campaign on understanding attitudes towards the Blue Reliever Asthma Inhaler and reliance on it
05 May 2022
Psychometric properties of the Spanish version of the SABA Reliance Questionnaire (SRQ) among Spanish asthma patients.
05 May 2022
Evaluating the Reliever Reliance Test in community pharmacy: a study in London, UK, focusing on service delivery
15 May 2023